C12N 2506/11
From blood or immune system cells
Official title: from blood or immune system cells
C12N2506/11 (From blood or immune system cells) appears on 332 US grants and 821 published applications in this corpus.
Search patents in C12N- Granted patents
- 332
- Published applications
- 821
- Assignees
- 406
- Inventors
- 1,539
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 1 |
| 2002 | 0 | 3 |
| 2003 | 0 | 10 |
| 2004 | 0 | 8 |
| 2005 | 0 | 10 |
| 2006 | 3 | 13 |
| 2007 | 3 | 6 |
| 2008 | 1 | 12 |
| 2009 | 6 | 8 |
| 2010 | 2 | 15 |
| 2011 | 3 | 17 |
| 2012 | 5 | 17 |
| 2013 | 6 | 18 |
| 2014 | 13 | 21 |
| 2015 | 12 | 43 |
| 2016 | 21 | 33 |
| 2017 | 13 | 37 |
| 2018 | 21 | 34 |
| 2019 | 18 | 56 |
| 2020 | 19 | 57 |
| 2021 | 21 | 67 |
| 2022 | 24 | 86 |
| 2023 | 25 | 68 |
| 2024 | 45 | 62 |
| 2025 | 41 | 67 |
| 2026 | 29 | 52 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Media and methods for differentiating natural killer cells1 Sep 2026US 12,723,233 B2Stemcell Technologies Canada Inc.
- Hematopoietic progenitor cell marker11 Aug 2026US 12,703,852 B2Kyoto University
- Compositions and methods related to megakaryocyte-derived extracellular vesicles4 Aug 2026US 12,697,307 B2STRM.bio Incorporated
- Methods for production of platelets from pluripotent stem cells and compositions thereof4 Aug 2026US RE50,977 E1Astellas Institute for Regenerative Medicine
- Immune cells derived from induced pluripotent stem cell14 Jul 2026US 12,680,075 B2Children's Medical Center Corporation
- Cd4+ cytotoxic t cells and methods of use thereof8 Oct 2026US 2026/0308522 A1Dana-Farber Cancer Institute, Inc.
- Method for modulating the differentiation and functions of human dendritic cells1 Oct 2026US 2026/0297524 A1Centre National De La Recherche Scientifique
- Compositions, systems and methods for programming immune cell function through targeted gene regulation1 Oct 2026US 2026/0297545 A1Duke University
- Methods of producing matured dendritic cells for immunotherapy24 Sep 2026US 2026/0284105 A1Hong Kong Baptist University
- Method for producing group 2 innate lymphoid cells24 Sep 2026US 2026/0286297 A1Astellas Pharma Inc.
Most cited
By later US patents
- Integration-free human induced pluripotent stem cells from blood73US 8,048,675 B1iPierian, Inc. · 2011
- Method of increasing the relative number of CD34.sup.+ cells in a cell population44US 6,090,625 A2000
- Mesenchymal stromal cells and uses related thereto28US 8,962,321 B2Ocata Therapeutics, Inc. · 2015
- Cancer vaccines and vaccination methods27US 8,097,256 B2Cedars-Sinai Medical Center · 2012
- Agent for the treatment and/or prophylaxis of an autoimmune disease and for the formation of regulatory T cells26US 9,616,105 B2AiCuris GmbH & Co. KG · 2017